Use of Silver Nanostructures on Microtransponders in an Ultra Sensitive Assay

StatusFinished
Effective start/end date1/09/1031/08/12

Funding

  • PharmaSeq, Inc.: $107,437.00

Keywords

  • Cancer Research, Cardiovascular Research, Nanotechnology